Matrix Metalloproteinase Inhibitors

All categories
DBCAT001461Pharmacologic class

Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES. A DrugBank category of 7 drugs. 1 of them is approved.

Also known as
Collagenase Inhibitors · Gelatinase Inhibitors · Inhibitors, Collagenase · Inhibitors, Gelatinase · Inhibitors, Matrix Metalloproteinase
Drugs

What you can answer from here — as of August 24, 2016

7DrugsEach linked to its full drug card
Listed above
16Drug targetsEvery drug–target pair in the class, with bond type
Sign in
1Marketed productAcross the regions we cover, with dosage forms and routes
Sign in
1Route of administrationHow the drugs in this class are given
Sign in

Which targets do Matrix Metalloproteinase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In